Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 03-2020 | 03-2019 | 03-2018 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,088 | -2,240 | -9,279 | -3,673 | 3,811 |
| Depreciation Amortization | 1,525 | 1,511 | 1,257 | 996 | 715 |
| Accounts receivable | 611 | -2,785 | -546 | 258 | 596 |
| Other Working Capital | -2,058 | -3,207 | -990 | 928 | -4,557 |
| Other Operating Activity | -1,972 | 4,928 | 2,765 | -3,318 | -8,449 |
| Operating Cash Flow | $3,194 | $-1,794 | $-6,793 | $-4,809 | $-7,884 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -263 | -35 | -19 | -181 | -1,098 |
| Purchase Sale Intangibles | N/A | N/A | 350 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 350 | -94 | -7 |
| Investing Cash Flow | $-263 | $-35 | $331 | $-275 | $-1,105 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,014 | N/A | N/A | N/A | N/A |
| Debt Repayment | -105 | N/A | N/A | N/A | -220 |
| Common Stock Issued | 42 | 1,438 | 2,064 | 2,354 | 9,450 |
| Other Financing Activity | -1,821 | -749 | -497 | -682 | -1,158 |
| Financing Cash Flow | $-870 | $690 | $1,567 | $1,671 | $8,071 |
| Beginning Cash Position | 1,537 | 2,676 | 7,571 | 10,984 | 11,512 |
| End Cash Position | 3,598 | 1,537 | 2,676 | 7,571 | 10,595 |
| Net Cash Flow | $2,061 | $-1,139 | $-4,895 | $-3,413 | $-918 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,194 | -1,794 | -6,793 | -4,809 | -7,884 |
| Capital Expenditure | -330 | -35 | -19 | -181 | -1,098 |
| Free Cash Flow | 2,864 | -1,829 | -6,812 | -4,990 | -8,982 |